How modern infostealers target macOS systems, leverage Python‑based stealers, and abuse trusted platforms and utilities to distribute credential‑stealing payloads.

Discover the best AI content detectors in 2026. Compare Winston AI, GPTZero, Originality.AI, and more for accuracy, trust, ...

Another chilly evening in Western Europe, as Elliot Williams is joined this week by Jenny List to chew the fat over the ...

ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that ...

Experts are sounding the alarm over YouTube’s deepfake detection tool — a new safety feature that could allow Google to train its own AI bots with creators’ faces, according to a report. The tool ...

A YouTube tool that uses creators' biometrics to help them remove AI-generated videos that exploit their likeness also allows Google to train its AI models on that sensitive data, experts told CNBC.

Presentation Attack Detection (PAD) systems rely on analyzing facial dynamics, particularly the movement of eyes and mouth regions, to distinguish between live faces and spoofing attempts. Face mask ...

EXCLUSIVE: Peacock has decided not to renew Poker Face for a third season. Natasha Lyonne exits as star, but series creator Rian Johnson, his T-Street partner Ram Bergman, MRC and Lyonne think there ...

Phase 3 AQUILA study showed DARZALEX FASPRO ® significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to active monitoring Landmark approval supports ...

YouTube is expanding its likeness detection tool to all monetized channels, allowing them to detect and request removal of AI videos using their face. YouTube is beginning to expand access to its ...

YouTube revealed on Tuesday that its likeness-detection technology has officially rolled out to eligible creators in the YouTube Partner Program, following a pilot phase. The technology allows ...

RARITAN, N.J., Oct. 16, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma therapies, today announced positive topline results from the investigational Phase 3 ...